| scholarly article | Q13442814 |
| P50 | author | Murray B. Stein | Q57416070 |
| Laura B Ngwenya | Q80145588 | ||
| Pavan S Upadhyayula | Q89880184 | ||
| Caitlin K Robinson | Q90097371 | ||
| Romain Pirracchio | Q90421046 | ||
| Phiroz E Tarapore | Q90483302 | ||
| Catherine G Suen | Q94542415 | ||
| Ethan Winkler | Q95935170 | ||
| Hansen Deng | Q96103742 | ||
| Geoffrey T. Manley | Q111306825 | ||
| John K. Yue | Q39048470 | ||
| Adam R. Ferguson | Q39048498 | ||
| P2093 | author name string | John F Burke | |
| Sourabh Sharma | |||
| P2860 | cites work | Sertraline-augmented lithium therapy of organic mood syndrome | Q48581362 |
| Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis | Q48708119 | ||
| Speech dysfunction due to trazodone--fluoxetine combination in traumatic brain injury | Q48739670 | ||
| Impact of pharmacological treatments on cognitive and behavioral outcome in the postacute stages of adult traumatic brain injury: a meta-analysis | Q48824804 | ||
| Axis I and II psychiatric disorders in patients with traumatic brain injury: a 12-month follow-up study | Q48931913 | ||
| Paroxetine versus citalopram treatment of pathological crying after brain injury. | Q51084469 | ||
| Relationship between depression and psychosocial functioning after traumatic brain injury. | Q51941658 | ||
| Psychiatric challenges in the first 6 years after traumatic brain injury: cross-sequential analyses of Axis I disorders. | Q51941661 | ||
| Sertraline in the treatment of major depression following mild traumatic brain injury. | Q52547580 | ||
| Synthesis of serotonin in traumatized rat brain | Q57043204 | ||
| CSF Neurotransmitter metabolites in comatose head injury patients during changes in their clinical state | Q60619418 | ||
| Maintenance Phase Efficacy of Sertraline for Chronic Depression A Randomized Controlled Trial | Q60620316 | ||
| Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells | Q62587219 | ||
| Improved arousal and initiation following tricyclic antidepressant use in severe brain injury | Q70881761 | ||
| Effect of acute fluoxetine treatment on the brain serotonin synthesis as measured by the alpha-methyl-L-tryptophan autoradiographic method | Q72334816 | ||
| Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study | Q73326033 | ||
| Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD) | Q24242402 | ||
| A rating scale for depression | Q24564540 | ||
| A review of screening tests for cognitive impairment | Q24678263 | ||
| Neurobiological consequences of traumatic brain injury | Q26852324 | ||
| The postconcussion syndrome and the sequelae of mild head injury | Q28202589 | ||
| Post concussion syndrome | Q28273997 | ||
| Mood disorders following traumatic brain injury | Q28274006 | ||
| Fluoxetine as a treatment for emotional lability after brain injury | Q28289252 | ||
| Control of depression with fluoxetine and antiseizure medication in a brain-injured patient | Q28324507 | ||
| Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial | Q28377040 | ||
| Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants | Q29547516 | ||
| Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus | Q29619400 | ||
| Cognitive improvement with treatment of depression following mild traumatic brain injury | Q31845756 | ||
| Rate of psychiatric illness 1 year after traumatic brain injury. | Q33542058 | ||
| Panic disorder in a patient with traumatic brain injury: a case report and discussion | Q33744246 | ||
| Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies | Q33809336 | ||
| Treatment for depression after traumatic brain injury: a systematic review | Q33829336 | ||
| Genetic epidemiology of major depression: review and meta-analysis | Q33919509 | ||
| The selective 5-HT(1A) receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats | Q33955086 | ||
| Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study | Q33956204 | ||
| Can traumatic brain injury cause psychiatric disorders? | Q34012791 | ||
| Selective serotonin reuptake inhibitor antidepressants potentiate methylphenidate (Ritalin)-induced gene regulation in the adolescent striatum. | Q34065820 | ||
| SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. | Q34067137 | ||
| Obsessive-complusive disorder: pharmacological treatment | Q34120078 | ||
| Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study | Q34142336 | ||
| The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability | Q34370348 | ||
| The Rivermead Post Concussion Symptoms Questionnaire: a confirmatory factor analysis | Q34576459 | ||
| Psychostimulant use in the rehabilitation of individuals with traumatic brain injury | Q34727002 | ||
| Serotonin agents in the treatment of acquired brain injury. | Q34727014 | ||
| The impact of traumatic brain injuries: a global perspective. | Q34731059 | ||
| Mood and behavioural disorders following traumatic brain injury: clinical evaluation and pharmacological management | Q43549116 | ||
| Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes | Q43572710 | ||
| A case of antidepressant-induced akathisia in a patient with traumatic brain injury | Q43603030 | ||
| Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression | Q43728696 | ||
| The 5-HTTPR*S/*L polymorphism and aggressive behavior in Alzheimer disease | Q43739300 | ||
| Up-regulation of 5-HT2B receptor density and receptor-mediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration | Q43945872 | ||
| Hypomania induced by herbal and pharmaceutical psychotropic medicines following mild traumatic brain injury | Q43959255 | ||
| Fluoxetine for OCD after brain injury | Q43977666 | ||
| Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial | Q44054269 | ||
| Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo | Q44084367 | ||
| Prevalence of long-term disability from traumatic brain injury in the civilian population of the United States, 2005. | Q44486380 | ||
| Symptoms at one year following concussion from minor head injuries | Q44498930 | ||
| Therapeutic effects of milnacipran (serotonin noradrenalin reuptake inhibitor) on depression following mild and moderate traumatic brain injury | Q44556203 | ||
| Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades | Q44892578 | ||
| BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders | Q45063753 | ||
| Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury | Q45217568 | ||
| Overlap of mild TBI and mental health conditions in returning OIF/OEF service members and veterans. | Q45331829 | ||
| A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder | Q45332570 | ||
| Exploring the convergence of posttraumatic stress disorder and mild traumatic brain injury | Q46419907 | ||
| Pharmacological treatment of neurobehavioural sequelae of traumatic brain injury | Q46742087 | ||
| Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. | Q46767739 | ||
| An open-label study of citalopram for major depression following traumatic brain injury | Q46798720 | ||
| Selective serotonin reuptake inhibitor treatment of post-traumatic Klüver-Bucy syndrome | Q48286895 | ||
| Mild traumatic brain injuries: the impact of early intervention on late sequelae. A randomized controlled trial | Q48298221 | ||
| Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine | Q48311985 | ||
| Rapid response of emotional incontinence to selective serotonin reuptake inhibitors | Q48351030 | ||
| Quantification of post-concussion symptoms 3 months after minor head injury in 100 consecutive patients | Q48382868 | ||
| The neuropsychiatry of depression after brain injury. | Q48417207 | ||
| Trajectories of life satisfaction in the first 5 years following traumatic brain injury | Q48514995 | ||
| Therapeutic potential of fluoxetine in neurological disorders | Q34778793 | ||
| Rates of major depressive disorder and clinical outcomes following traumatic brain injury | Q34956565 | ||
| Melatonin and melatonergic drugs on sleep: possible mechanisms of action | Q34970081 | ||
| Genetic predictors of response to treatment with citalopram in depression secondary to traumatic brain injury. | Q35124115 | ||
| Cognitive impairment following closed head injury | Q35529302 | ||
| The Epidemiology of Traumatic Brain Injury: A Review | Q35544377 | ||
| Predicting postconcussion syndrome after mild traumatic brain injury in children and adolescents who present to the emergency department. | Q35705696 | ||
| Pharmacological management of the psychiatric aspects of traumatic brain injury | Q35847232 | ||
| Methylphenidate: mechanism of action and clinical update | Q35887122 | ||
| Insomnia following traumatic brain injury: a review | Q36019499 | ||
| Cortisol Supplement Combined with Psychotherapy and Citalopram Improves Depression Outcomes in Patients with Hypocortisolism after Traumatic Brain Injury | Q36314841 | ||
| Traumatic brain injury and sleep disorders | Q36352054 | ||
| Sleep in adults with attention deficit hyperactivity disorder (ADHD) before and during treatment with methylphenidate: a controlled polysomnographic study | Q36513253 | ||
| Pharmacological enhancement of cognitive and behavioral deficits after traumatic brain injury | Q36653058 | ||
| Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment. | Q37196141 | ||
| Depression and cognitive complaints following mild traumatic brain injury | Q37504378 | ||
| The psychiatric sequelae of traumatic injury | Q37667315 | ||
| The epidemiology of traumatic brain injury | Q37710314 | ||
| A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury | Q38373813 | ||
| Sertraline for Preventing Mood Disorders Following Traumatic Brain Injury: A Randomized Clinical Trial. | Q38387555 | ||
| Update on TBI and Cognitive Impairment in Military Veterans | Q38571987 | ||
| Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment | Q39128639 | ||
| Relief of serotonin selective reuptake inhibitor induced sexual dysfunction with low-dose mianserin in patients with traumatic brain injury | Q39405960 | ||
| Construct validity and reliability of the Rivermead Post-Concussion Symptoms Questionnaire | Q39738080 | ||
| A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury | Q39883209 | ||
| Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death | Q40378569 | ||
| Serotonin-dopamine interaction and its relevance to schizophrenia | Q40945989 | ||
| Postconcussion symptoms | Q41560043 | ||
| Role of sertraline in posttraumatic brain injury depression and quality-of-life in TBI | Q42142199 | ||
| Dystonia associated with sertraline | Q42536270 | ||
| Fluoxetine's effects on cognitive performance in patients with traumatic brain injury | Q42600509 | ||
| Managing depression in brain injury rehabilitation: the use of an integrated care pathway and preliminary report of response to sertraline | Q42676479 | ||
| Impact of early administration of sertraline on cognitive and behavioral recovery in the first year after moderate to severe traumatic brain injury. | Q43134573 | ||
| The neurobiology of depression--revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies | Q43182877 | ||
| Impact of early administration of sertraline on depressive symptoms in the first year after traumatic brain injury | Q43237796 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P921 | main subject | traumatic brain injury | Q1995526 |
| P577 | publication date | 2017-07-25 | |
| P1433 | published in | Brain Sciences | Q27724596 |
| P1476 | title | Selective Serotonin Reuptake Inhibitors for Treating Neurocognitive and Neuropsychiatric Disorders Following Traumatic Brain Injury: An Evaluation of Current Evidence | |
| P478 | volume | 7 |
| Q90097374 | Age and sex-mediated differences in six-month outcomes after mild traumatic brain injury in young adults: a TRACK-TBI study |
| Q92810187 | Approaches to Monitor Circuit Disruption after Traumatic Brain Injury: Frontiers in Preclinical Research |
| Q90259463 | Cannabis in the Treatment of Traumatic Brain Injury: A Primer for Clinicians |
| Q90668341 | Concussion and Mild-Traumatic Brain Injury in Rural Settings: Epidemiology and Specific Health Care Considerations |
| Q64086898 | Employment Status Among U.S. Military Veterans With Traumatic Brain Injury: Mediation Analyses and the Goal of Tertiary Prevention |
| Q61449890 | Impact of Traumatic Brain Injury on Neurogenesis |
| Q57157638 | Neurotransmitter changes after traumatic brain injury: an update for new treatment strategies |
| Q89880187 | The Role of Blood Biomarkers for Magnetic Resonance Imaging Diagnosis of Traumatic Brain Injury |
Search more.